211At-BC8-B10
N/A
Report date: 2025/09/12 20:01:19
Base Information
Drug Name211At-BC8-B10
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research CenterNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesNational Cancer InstituteFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active Indications +[8]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A